Inspiration Biopharmaceuticals names John Butler as ceo
Replaces Michael Griffith who takes position of cso
Butler has joined Inspiration from Genzyme, which was acquired by Sanofi in April. While at Genzyme, he was most recently president of the company's rare genetic diseases business. He also led the company's renal, endocrinology, and cardiovascular businesses.
Prior to Genzyme, Butler held sales and marketing positions at Amgen and Hoffmann-La Roche.
You may also like
Cleaning
Guardtech partner with Intense Pulsed Light innovators Biopulz to offer game-changing new cleanroom decontamination solution
New partnership will give Guardtech clients access to Biopulz’s mobile Eloane tower and integrated E-z̈o IPL decontamination system as part of their cleanroom installation projects
Analysis
Inspection readiness should be part of normal operations
For routine surveillance inspections, readiness cannot depend on receiving advance notice. Inspection readiness should be embedded in everyday operations, while recognising that preparation may need to become more intensive ahead of a known regulatory milestone
Pharmaceutical
T-Cypher Bio relocates to new Oxford facility to advance immune engager pipeline
The biotech firm has moved to a new facility at Abingdon Science Park, expanding its laboratory and tissue culture capabilities to support IND-enabling studies and the development of next-generation T-cell receptor-based therapeutics